Why specialty care may be the next major opportunity for risk-bearing organizations
For years, risk-bearing organizations have invested in identifying risk, closing care gaps, and strengthening primary care. Those investments remain essential. But with medical costs rising and margins under pressure, identifying risk is no longer enough. Organizations must also influence the clinical decisions that determine what care patients receive, where they receive it, and what it ultimately costs.
That raises an important question: Have we changed how healthcare is paid without sufficiently changing how it is delivered?
The Specialty Care Disconnect
Primary care has rightly been the foundation of value-based care. Yet many of the decisions that drive downstream medical spending occur beyond the primary care setting, where traditional fee-for-service incentives continue to shape how care is delivered.
A referral can initiate a series of consultations, diagnostic tests, procedures, and follow-up visits. Each may be clinically appropriate, but the system often lacks consistent accountability for whether the overall course of care produces the best outcome at the most appropriate cost.
Consider coronary artery disease. Depending on which specialist evaluates a patient, treatment recommendations may range from medical management to stenting or surgery. Patient-specific factors matter, but variation in practice patterns raises a difficult question: How much does the provider a patient sees influence the care they receive?
For risk-bearing organizations, the implications extend beyond individual treatment decisions. Primary care teams may be accountable for a patient's total cost of care while having limited visibility into, or influence over, the specialty pathways that follow a referral.
This disconnect is reinforced by three persistent challenges: financial incentives that reward utilization, fragmented clinical decision-making, and limited accountability for outcomes across the continuum of care.
Better Contracts Won't Fix a Fragmented Delivery System
Much of the effort to bring specialty care into value-based arrangements has focused on contracting, network design, and reimbursement. These are important levers, but they don't necessarily change the clinical decisions driving utilization.
Negotiating a lower rate for a procedure doesn't address whether it was necessary. Directing patients to preferred specialists doesn't guarantee consistent, evidence-based treatment. And improving referral efficiency doesn't help if the underlying care pathway remains fragmented.
The more consequential opportunity is to rethink how specialty expertise is used.
Sometimes the best specialty visit is the one that never needs to happen because a primary care physician has the guidance to manage the patient effectively. In other cases, earlier specialist involvement can prevent disease progression, unnecessary emergency care, or hospitalization.
The objective isn't fewer referrals or procedures. It's ensuring that clinical decisions reflect patient needs, supported by evidence and appropriate expertise, rather than the incentives or limitations of the traditional delivery system.
Focus on the Decisions That Drive Cost
Transforming specialty care across an entire population is a daunting proposition. A more practical starting point is to identify specific conditions and care pathways where different clinical decisions could meaningfully improve outcomes and financial performance.
Cardiovascular disease offers one example. Heart failure and atrial fibrillation can progress undetected or undertreated until patients experience costly complications. Earlier diagnosis and treatment may change that trajectory. At the same time, not every patient with cardiovascular disease requires ongoing specialist visits or procedural intervention.
The opportunity is to distinguish between patients who need more intensive specialty care and those who can be managed effectively with appropriate clinical guidance.
For risk-bearing organizations, three questions can help identify where to focus:
- Where is clinical variation contributing to potentially avoidable costs? Examine differences in referral patterns, procedures, and treatment approaches to identify opportunities for more consistent, evidence-based care.
- Where could earlier intervention change the outcome? Prioritize conditions where timely diagnosis and treatment can prevent deterioration or expensive acute events.
- Can the impact be demonstrated? Measure clinical outcomes, appropriate utilization, and risk-adjusted total cost of care, rather than relying solely on activity metrics.
These questions can help organizations move beyond broad ambitions for specialty transformation toward targeted programs with defined populations, interventions, and measurable results.
The Next Chapter Requires Different Decisions
Value-based care has made meaningful progress in aligning financial accountability with patient outcomes. But financial incentives alone cannot transform a delivery system that still operates largely around individual encounters and procedures.
The next phase will require greater attention to the clinical decisions that drive medical expense, stronger alignment between primary and specialty care, and more rigorous measurement of what actually improves outcomes.
Primary care will remain the foundation of value-based care. But for organizations searching for the next dollar of savings, the opportunity may lie in what happens after the referral, or whether that referral was needed in the first place.